c-Fos is a multifunctional transcription factor that is involved in cellular proliferation, differentiation and apoptosis. c-Fos is rapidly induced by a variety of hormones, growth factors and other extracellular stimuli, resulting in cell-specific responses. One potential mechanism underlying the cell-specific effects of c-Fos may be its ability to regulate gene expression through interaction with tissue-restricted transcription factors. We report here that c-Fos interacts with the cell-specific GATA proteins to potentiate their ability to transactivate target promoters, via GATA-binding sites. c-Fos is recruited to GATA proteins through direct interaction with their N-terminal activation domain. Neither the leucine zipper nor the DNA-binding domain of c-Fos is required for physical interaction with GATA proteins. Instead, a C-terminal domain located between amino acids 235 and 296, which is conserved in FosB but not in the nontransforming Fos family members, FosB/SF or Fra-1, is essential for c-Fos-GATA interaction. These data suggest that c-Fos may act as an inducible cofactor for cell-specific transcription factors and unravel a novel mechanism for transcriptional regulation by c-Fos, independent of the well-studied AP-1 pathway. The results also raise the possibility that dysregulated interaction with cell-specific transcription factors may be an important component in cellular transformation by nuclear oncogenes.
Introduction c-Fos is a multifunctional transcription factor that plays an important role in proliferation, differentiation and apoptosis of specific cell types. c-Fos is one of the earliest growth and stress response genes and its induction is thought to contribute to the regulation of downstream target genes through heterodimerization with Jun family members and activation of AP-1-dependent promoters (reviewed in Jochum et al., (2001) ; Shaulian and Karin (2002) ). c-Fos also plays an essential role in cell differentiation particularly in the hematopoietic system, where it is a key lineage determination factor (Lord et al., 1993; Grigoriadis et al., 1994; Hosoda et al., 1994; Matsuo et al., 2000; Miyamoto et al., 2001; Takayanagi et al., 2002) . Targeted mutagenesis of the c-Fos gene reduces viability at birth to 40%; surviving Fos null mice show, among other abnormalities, severe bone and hematopoietic defects including a block in the differentiation of myeloid cells into osteoclasts and marked inhibition of B-and T-cell development (Johnson et al., 1992; Wang et al., 1992) . Moreover, cells lacking c-Fos exhibit impaired responsiveness to external stimuli and to growth factors, and are hyper-responsive to UV radiation, resulting in increased apoptosis and reduced cell cycle re-entry (Hu et al., 1994; Schreiber et al., 1995; Wenzel et al., 2002) . Finally, c-Fos is required for malignant progression of skin and other solid tumors like fibrosarcomas, possibly through its activation of tumor metalloproteases and growth factors required for angiogenesis (Saez et al., 1995) .
The mechanisms underlying c-Fos pleiotropic effects remain largely undefined, although it is widely assumed that they involve cell-specific post-translational modifications and protein-protein interactions at target promoters. c-Fos contains several phosphorylatable residues in transcriptionally active domains, and mitogen-activated protein kinase (MAPK)-mediated phosphorylation is likely involved in cell-and gene-specific effects of c-Fos (Ofir et al., 1990; Deng and Karin, 1994; McBride and Nemer, 1998) . Recent analysis of Drosophila Fos further supports the role of cell-specific phosphorylation of Fos in mediating specific responses (Ciapponi et al., 2001) .
In addition to heterodimerizing with the Jun proteins, c-Fos also interacts with other members of the leucine zipper family of transcription factors such as the maf proto-oncogenes, which bind a distinct class of regulatory elements (Kataoka et al., 1996) . c-Fos can also interact with effectors of several signal transduction pathways. For example, c-Fos can modulate transcription by interacting with the calcineurin-activated nuclear factor of activated T cells (NFAT) proteins; NFAT and the Fos/Jun heterodimer bind cooperatively to composite DNA sites present on cytokine genes Macian et al., 2000) . c-Fos was also shown to interact with NFkB (Stein et al., 1993) and with the coactivator CBP (Bannister and Kouzarides, 1995) . Finally, c-Fos can repress transcription through protein-protein interactions with nuclear receptors, as demonstrated by the interaction with the glucocorticoid and vitamin A and D receptors. These interactions may be relevant to the anti-inflammatory and immunosuppressive effects of glucocorticoids and to the differentiation-promoting effects of vitamins A and D (Karin and Chang, 2001 ). In contrast, few studies have addressed the interaction of c-Fos with tissue-specific transcription factors; the interaction between Fos and the myogenic factor MyoD was shown to prevent myogenic differentiation and cause transformation of myoblasts (Lassar et al., 1989; Li et al., 1992) . Whether c-Fos interacts with other classes of tissue-specific transcription factors to enhance their activity has not been addressed.
GATA proteins are tissue-restricted transcription factors that bind a WGATAR DNA motif through a zinc-finger DNA-binding domain and play a critical role in cell survival and differentiation. The vertebrate GATA proteins are subdivided into two groups, based on sequence homology and expression pattern (Lowry and Atchley, 2000) . The first subgroup includes GATA-1, -2 and -3, which are essential for various aspects of hematopoiesis and neurogenesis (Kuo and Leiden, 1999; Lim et al., 2000; Cantor and Orkin, 2002) , while the second group includes GATA-4, -5 and -6, which are important for endoderm and cardiovascular development (reviewed in Nemer and Nemer (2003) .
Several observations suggest that c-Fos may functionally interact with the zinc-finger family of GATA proteins. First, both c-Fos and members of the GATA family are required for normal hematopoiesis, including progenitor cell proliferation and myeloid and T-cell differentiation (Johnson et al., 1992; Wang et al., 1992; Lord et al., 1993; Tsai et al., 1994; Shivdasani et al., 1997; Zheng and Flavell, 1997) . Moreover, the IL-5 Tcell-specific promoter has been shown to require both AP-1 and GATA elements for its activity, and cotransfected GATA proteins can activate the promoter only in the presence of phorbol ester stimulation, which induces Jun and Fos proteins (Yamagata et al., 1995) . In the heart, hypertrophic growth is associated with activation of immediate early genes including c-Fos, as well as upregulation of transcription factor GATA-4, an essential modulator of cardiomyocyte response to hormones and growth factors (Pandey et al., 1986; Charron et al., 2001; Liang et al., 2001) . Furthermore, in vivo induction of angiotensin receptor transcription in response to hypertrophic stimulation requires both AP-1 and GATA elements (Herzig et al., 1997) . Several other GATA target and hypertrophy-inducible genes such as atrial natriuretic peptide (ANP) and endothelin I are also activated by Jun/Fos; interestingly, in the case of endothelin-1, the Jun/Fos heterodimer was found to cooperate with GATA-2 to activate transcription (Kawana et al., 1995) . In the present study, we tested the ability of c-Fos to potentiate transcriptional activity of the tissue-specific GATA proteins. The results show that c-Fos physically and functionally interacts with GATA proteins and can activate transcription through GATA-dependent recruitment to target promoters. The basic and leucine zipper domains of c-Fos are dispensable for c-Fos-GATA interaction, which requires instead a C-terminal domain that is conserved in v-Fos and FosB but not in other Fos proteins. This identifies a novel pathway for transcriptional activation by c-Fos, which may contribute to its cell-specific actions.
Results

c-Fos potentiates GATA-4-dependent transcription
To test whether c-Fos modulates GATA-dependent transcription, we used the ANP promoter, which is a well-established GATA target (Durocher et al., 1997; Charron et al., 1999; Morin et al., 2001) . Cotransfection experiments were carried out in F9 cells, which contain no detectable AP-1 or GATA activity, as well as in HeLa or NIH3T3 cells, which contain abundant c-Jun but not c-Fos proteins. The À135 bp ANP promoter contains a high-affinity GATA-binding site around À120 bp, but no AP-1-binding (TRE) sites (McBride and Nemer, 1998; Charron et al., 1999) . As shown in Figure 1a , c-Fos alone had little effect on ANP promoter activity but, when co-expressed with GATA-4, it potentiated by at least 10-fold GATA-4 transcriptional activation, resulting in 50-fold induction of ANP promoter activity. This effect was dependent on GATA-4 binding to the promoter, and mutation of the À120 bp GATA element abrogated c-Fos transcriptional effects. Potentiation of GATA-dependent transcription was not restricted to F9 cells, and was similarly observed in other cell types including fibroblast and epithelial cell lines (Figure 1b and data not shown). Interestingly, ectopic expression of c-Fos in GATA-2-containing HeLa cells was sufficient to upregulate a GATA-driven heterologous promoter (2 Â GATA-TK 81 -luc), indicating that endogenous GATA factors are able to recruit c-Fos to GATA target promoters (Figure 1c) . Together, these results are consistent with a role for GATA factors in mediating cell-specific effects of c-Fos. It was also noteworthy that the effect of c-Fos on GATA-dependent transcription was at least as significant as, and in fact, consistently greater than, c-Fos potentiation of cJun activation of AP-1-dependent promoters (Figure 1d ). Other GATA-dependent promoters, including the cardiac-specific B-type natriuretic peptide (BNP) (Gre´pin et al., 1994) , the endothelial endothelin-1 and the hematopoietic cell-specific SCL (Bockamp et al., 1998) , as well as the growthinducible c-Jun promoter (which contains a high affinity GATA-binding site at À30 bp), were also synergistically activated by c-Fos and GATA-4 (Figure 2 ). Synergy was also observed on a minimal BNP promoter containing either one or three GATA elements (3xGATA), further indicating that c-Fos is able to activate transcription via GATA-binding sites (Figure 2 and data not shown). Next, we tested the ability of other members of the Fos and GATA families to cooperatively induce transcription. As shown in Figure 3a , several members of the GATA family were able to cooperate with c-Fos to synergistically induce transcription from target promoters. However, collaboration with GATA factors was not a shared property of all Fos proteins. Both FosB and v-Fos were able to synergize with GATA-4, but Fra1 expression had no effect on GATA-4 activation ( Figure 3c ). Other members of the basic leucine zipper family, including CREB and ATF1, did not support synergy with GATA-4, while c-Jun and JunB showed at best a modest two fold synergy ( Figure 3b) . A structurefunction study indicated that, in addition to intact DNA-binding activity, synergy required an N-terminal region of the GATA-4 transcriptional activation domain (Figure 3c, d ).
c-Fos physically interacts with GATA-4
The results described above suggested that GATA proteins may directly contact c-Fos. The capacity of cFos and GATA-4 to physically interact was initially examined using pull-down assays with polyhistidinetagged GATA proteins. Expression of all proteins used was confirmed by translating them in reticulocyte lysate and subjecting them to SDS-PAGE ( Figure 4c ). Wildtype and mutant GATA proteins were then coexpressed with full-length c-Fos (Figure 4a ) for subsequent pulldown assays. The polyhistidine-tagged wild-type and mutant GATA-4 proteins were effectively retained by the nickel resin as expected, while c-Fos was retained only in the presence of certain GATA proteins ( Figure 4b ). Full-length and C-terminally truncated GATA-4 proteins were the most efficient at interacting with c-Fos; deletion of the GATA-4 N-terminal retained the ability to interact with c-Fos, albeit at significantly lower levels compared to the intact GATA-4 protein (compare the ratio of GATA-4 to Fos in the different lanes of panel b). Deletion of the basic region and a Cterminal extension (D303-390) abrogated physical interaction with c-Fos. These results suggest that at least two domains of GATA-4 are required for stable interaction with c-Fos. Association of c-Fos and GATA-4 was also observed in vivo in nuclear extracts from 293 cells transiently transfected with Flag-tagged GATA-4. As shown in Figure 4d , endogenous c-Fos coimmunoprecipitated only from GATA-4-containing extracts.
The observation that GATA-4 efficiently contacted c-Fos, prompted us to test whether GATA-4 could compete with c-Jun for c-Fos binding. Purified c-Jun c-Fos (McBride and Nemer, 1998) as well as bacterially produced MBP-GATA-4 were used in gel shift assays. Addition of increasing amounts of GATA-4 resulted in a drastic decrease of AP-1 binding ( Figure 5a) ; deletion of the N-terminal of GATA-4 eliminated this effect, consistent with the pull-down results that showed an involvement of the N-terminal region of GATA-4 in contacting c-Fos. c-Jun/c-Fos heterodimers were much more sensitive to GATA-4 than c-Jun homodimers, suggesting that GATA-4 may be more efficiently competing for c-Fos (Figure 5a ). There was no effect of either c-Fos or c-Jun on GATA binding to its DNA element, suggesting that c-Fos enhancement of GATA-4 action is not at the level of DNA binding. We further explored the mechanism of GATA-4 inhibition of AP-1 binding. We found that GATA-4 did not alter the dissociation constant (K off ) of the Jun/Fos heterodimer from DNA ( Figure 5d) ; rather, the presence of GATA-4 decreased the association rate (K on ) of the Jun/Fos heterodimer with DNA ( Figure 5e ). Given that c-Fos enhances Jun affinity to its DNAbinding site, the above results suggest that GATA-4 may Interaction between GATA and c-Fos was also evidenced by the ability of GATA proteins to potentiate transcriptional activation of a c-Fos-GAL4 chimera (Figure 6a ). In addition to GATA-4, other GATA proteins including GATA-2, -5 and -6 were able to potently enhance activation of the GAL4/c-Fos chimera (data not shown). This system was further used to more finely define regions in c-Fos responsible for GATA synergy. Several GAL4/c-Fos mutants were generated, and most of them exhibited almost wild-type transcriptional activation (Figure 6a ). However, deletion of AA 235-380, which removes all C-terminal activation modules, abrogated transcriptional activity, while deletion of the basic domain resulted in a hyperactive protein. As shown in Figure 6b , there was a drastic reduction of synergy with the GAL4/c-Fos 1-252 fusion; synergy was completely abrogated with further deletion to AA 235. In contrast, deletion of the basic region (DBD) of c-Fos exhibited wild-type synergy with GATA-4. Thus, the region between AA 235 and 296 of c-Fos appears to be a critical determinant of transcriptional synergy with GATA-4. The same mutants were generated in the context of the c-Fos protein and tested for their ability to transactivate a TRE-driven promoter in the presence of a c-Jun protein containing the basic and leucine zipper domains (Figure 6c ) or a GATA-dependent promoter in the presence of GATA-4 ( Figure 6d ). As expected, mutation or deletion of the leucine zipper and basic domains severely reduced the ability of c-Fos to activate the TRE-TK heterologous promoter; similarly, deletion of the C-terminal activation modules resulted in a progressive decrease in activity (Figure 6c ). This result is consistent with a previous finding that a c-Fos protein lacking AA 210-380, a region also required for interaction with the coactivator CBP, is transcriptionally inactive on a TREdriven promoter (Bannister and Kouzarides, 1995) . The C-terminal deletions also reduced c-Fos enhancement of GATA-4 activation of the À135 ANP promoter Figure 6d ) as well as that of the BNP promoter (data not shown). Thus, deletion of AA 297-380 reduced synergy by 30%, while further C-terminal truncation to AA 271 resulted in only threefold synergy, a loss of 80% relative to wild type. Deletions to AA 252 or AA 235 had similar effects (Figure 6d ). On the other hand, deletion of the basic region as well as mutations in the leucine zipper domain decreased, but did not abrogate synergy. Thus, sequences between AA 270 and 296 appear to be essential for c-Fos/GATA-4 synergy, while other domains of c-Fos may be differentially required for maximal activation of GATA target promoters.
Given these results, we tested whether AA 252-296 were needed for physical interaction with GATA-4, or whether requirement for this domain simply reflected the presence of an activation module. For this, coimmunoprecipitation assays of GATA-4 with wildtype and various c-Fos mutants were carried out (Figure 7) . Intact c-Fos, as well as c-Fos proteins harboring mutations in the leucine zipper (LZm) or deletions of either the basic domain (DBD) or of sequences from C-terminal to AA 296 were efficiently immunoprecipitated with GATA-4. However, deletion of AA 252-296 completely eliminated interaction with GATA-4, as evidenced by the inability of c-Fos 1-252 and c-Fos 1-235 to bring down GATA-4. These results map a novel protein-protein interaction domain on cFos and identify AA 252-296 as essential for physical interaction with GATA-4.
Discussion
Ever since the finding that c-Fos heterodimerizes with Jun proteins and is a component of the AP-1 complex that couples various cell surface signals to changes in gene expression and cell fate, numerous studies have attempted to elucidate the mechanisms of cell and signal The prevailing hypothesis that specificity may be achieved by formation of distinct AP-1 heterodimers implicitly implies that the various AP-1 members differentially interact with other transcription factors bound to target promoters or with other cellular cofactors. Alternatively, Fos and Jun proteins may regulate transcription via AP-1-independent pathways that involve recruitment to distinct DNA regulatory modules through protein-protein interactions. The data presented above demonstrate that c-Fos may indeed upregulate the transcription of cellspecific or growth-inducible genes, by potentiating the activity of the GATA family of cell-specific regulators. This result identifies a novel mechanism for c-Fos action, which could account for at least some of the cell-specific effects of c-Fos. Moreover, potentiation by c-Fos of cell-specific transcription factors may represent a paradigm for understanding the cell-specific effects of other hormone and growth factor-inducible ubiquitous transcription factors. In response to a large number of stimuli, including cellular stress, UV irradiation, growth factors and cytokines, transcription of AP-1 genes is rapidly induced with c-Fos mRNA and protein accumulation preceding upregulation of other immediate early genes. This time course suggests that at least some transcriptional effects of c-Fos may occur independent of AP-1. The finding that c-Fos transcriptionally activates the c-Jun promoter following recruitment by cell-specific transcription factors required for c-Jun expression, is consistent with the time course of Fos and Jun induction, and provides a molecular framework for further analysis of the role of c-Fos in regulating other genes of the immediate early response.
In addition to their role in embryonic development, GATA factors have been implicated in the response to several growth factors and signaling pathways. In the heart, GATA-4 is required for the action of the TGF-b family of cardiogenic inducers (Schultheiss et al., 1997) and for the response of differentiated myocytes to vasoactive peptides which cause hypertrophic growth (Charron et al., 2001) . Interestingly, upregulation of the GATA pathway by ectopic overexpression of GATA-4 is sufficient for inducing trophic growth (Charron et al., 2001) . Given that c-Fos is rapidly induced in response to vasoactive peptides and other hypertrophic stimuli (reviewed in Depre et al. (1998) , it is tempting to suggest that c-Fos potentiation of GATA-4 may be an important pathway responsible for the initiation of cardiac hypertrophy.
GATA proteins have been reported to interact with several other classes of transcription factors including the zinc finger FOG proteins, the homeodomain containing NK proteins as well as the MADS box factors Mef2 and SRF (reviewed in McBride and Nemer (2001) . In all cases, physical interaction is mediated by either the N-terminal zinc finger (in the case of FOG) or the C-terminal DNA-binding zinc finger (Durocher et al., 1997; Fox et al., 1998; Morin et al., 2000 Morin et al., , 2001 ). In the case of c-Fos, two regions appear to be crucial, the N-terminal activation domain and the basic region C-terminal of the second zinc finger, which were also found to be important for NkÂ2.5 interaction. The Nterminal region of GATA-4 contains an activation module between AA 1 and 92 (Figure 3b ). However, functional interaction with c-Fos is lost when AA 93-200 are deleted, although the truncated proteins retain 50% wild-type transcriptional activity and 100% DNAbinding activity (Figure 3b and data not shown). AA 93-200 contain several putative phosphorylation sites including a confirmed MAPK phosphorylation site at S105; mutation of this residue to alanine decreases GATA-4 transcriptional activity (Charron et al., 2001) and reduces by about two fold the Fos/GATA-4 synergy (our unpublished observation). Interestingly, the c-Fos protein contains an MAPK docking site (FKFP) at AA 272-275 (Jacobs et al., 1999; Fantz et al., 2001) . Mutation of F272-V, which abolishes MAPK binding, abrogated c-Fos/GATA-4 synergy (our unpublished observation), further implying a role for MAPK signaling in GATA/c-Fos synergy. Thus, it will be interesting in the future to examine the relevance of phosphorylation of GATA-4 and c-Fos to their functional interaction and the role of the GATA/c-Fos complex in transducing cell-specific MAPK signaling. On the other hand, the mapping of the GATA interaction domain on c-Fos to AA 250-290 identifies a novel protein-protein interaction domain on c-Fos, which may be relevant to the mechanism(s) of Fosinduced transformation. Indeed, a proline-rich region that is conserved at a similar position in the transforming members of the Fos family, namely v-Fos and FosB, is present between AA 247 and 284 of c-Fos. This region in c-Fos and Fos B lies within an activating module that is required, at least in the case of FosB, for cellular transformation (Sutherland et al., 1992; Wisdom et al., 1992) . This finding had led to the speculation that this domain may affect the activation of downstream AP-1-inducible genes required for transformation. Our finding that this domain is the major determinant of interaction with cell-specific GATA factors suggests that persistent presence of Fos protein -as observed with prolonged mitogenic stimulation or with the viral oncogenic v-Fos -may interfere with the differentiation program by sequestering cell-specific transcription factors or interfering with their interactions with other cofactors. Moreover, given that transformation results from both altered differentiation as well as dysregulated proliferation, the present findings provide a molecular basis for understanding the transforming ability of c-Fos, and opens the way for the identification of other cellrestricted Fos-interacting proteins relevant to cellular transformation or to cell-specific actions of various Fos family members.
Materials and methods
Expression vectors
Reporter plasmids containing the proximal 135 bp rat ANP promoter and the proximal 120 bp rat BNP promoter sequences as well as mutations therein, were described previously (McBride and Nemer, 1998; Morin et al., 2000; Bhalla et al., 2001) . The Jun-luc reporter was a kind gift of Dr Michael Karin (UCSD) and includes 1 kbp upstream sequences of the human jun gene, as described in Angel et al. (1988) . The SCL-luc construct was generously donated by Dr Trang Hoang (IRCM). It contains a 562 bp murine SCL promoter that is activated by GATA proteins through a conserved GATA motif located around À50 bp (Bockamp et al., 1998; Gottgens et al., 2002) . The GATA and TRE heterologous promoters were generated by inserting upstream of the À81 TK-luc reporter, one or more BamHI-BglII double-stranded oligonucleotides corresponding to either the À120 bp GATA-binding site of the rANP promoter (GATA-TK) or the collagenase TRE (TRE-TK) as previously described (McBride and Nemer, 1998) . A luciferase reporter containing a BamHI-BglII oligonucleotide corresponding to the high-affinity double GATA site of the rBNP promoter inserted in the BamHI site of the minimal (À60 bp) BNP promoter (which contains a GATA-binding site at À30 bp) was also used and referred to as 3xGATA (Gre´pin et al., 1994) . The eucaryotic expression vectors used for GATA-4, -5 and -6 were described in Morin et al. (2001) . The 3xUAS-luciferase plasmid was described in Charron et al. (2001) . For in vitro transcription/translation, wild-type and mutant rat GATA-4 cDNAs were subcloned in pCDNA3, as previously described (Charron et al., 1999) . Wild-type and mutant GATA-4 cDNAs were also subcloned in the CMV-driven pCGN expression vector to generate HA-tagged proteins. GATA-4 mutants were generated using PCR-mediated mutagenesis. Expression levels as well as proper nuclear localization of all mutants were verified by Western blot and immunohistochemistry using an HA antibody. For bacterial production of GATA-4, cDNA fragments corresponding to the coding sequences of GATA-4 and the N-terminal deleted mutant (del 1-200) were cloned in phase with MBP. The vector used and protocol for generating the recombinant proteins were as previously described (Morin et al., 2001) . For in vitro translation of c-Fos, the HindIII/ BamHI fragment of rat c-Fos was inserted into pCDNA3 and translated using the T7 promoter in this vector. GAL4/Fos fusions were generated by cloning PCR-generated BamHI/ EcoRI Fos fragments into the corresponding sites of PCDNA3/GAL4 1-147, which express the DNA-binding domain of GAL4. Eucaryotic expression vectors for the various AP-1 proteins were previously described (McBride and Nemer, 1998) . All constructs were confirmed by sequencing.
Cell culture and transfection
F9 cells were maintained in Dulbecco's modified Eagle medium (DMEM) plus 15% fetal bovine serum on plates coated with 0.1% gelatin. HeLa and NIH3T3 cells were maintained in DMEM containing 10% fetal bovine serum. 293 cells were maintained in DMEM containng 10% fetal bovine serum and 18 mm HEPES. Primary cultures of cardiomyocytes were performed as previously described (Morin et al., 2000) . Transfection of cells was by calcium phosphate precipitation, and cells were routinely harvested 36 h after transfection for luciferase assay. The transfection data reported are the mean of 3-10 independent experiments, each carried out in duplicate and using at least two different DNA preparations for all plasmids.
In vitro translation of GATA-4 and c-fos GATA-4 and c-Fos were cotranslated in the presence of 35 S-methionine and rabbit reticulocyte lysate using the TNT system as instructed by the manufacturer (Promega). The presence of full-length 35 S-labeled GATA-4 and c-Fos (or mutant) was confirmed by examination of the products on SDS-PAGE/autoradiography using standard protocols.
Pull-down assays
Wild-type or mutant GATA-4 proteins (histidine-tagged) were coexpressed with full-length c-Fos in vitro using rabbit reticulocyte lysate. Samples (10 ml) were rotated at 41C for 1 h in 400 ml of binding buffer (50 mm Tris-Cl (pH 7.5), 150 mm NaCl, 0.3% NP-40, 0.25% BSA, 1 mm DTT) followed by addition of 20 ml of nickel (Probond) resin (Invitrogen). After a further incubation of 2 h, the resin was washed with binding buffer five times, bound proteins were eluted by boiling in sample buffer and samples were subjected to SDS-PAGE.
35
S-labeled proteins were detected by autoradiography.
Immunoprecipitation
Lysates containing GATA-4 and c-Fos proteins were heat-treated for 3 min at 601C. Inputs were added to 400 ml of buffer (100 mm Tris-Cl (pH 7.4)/0.5% NP-40/ 400 mm NaCl/protease inhibitors) and incubated (with rotation) for 1 h at 41C with 5 ml of anti-c-Fos antibody c-Fos interaction with GATA factors K McBride et al (Oncogene Science). Protein A/G agarose (15 ml) was then added for a 30 min incubation at 41C. Samples were washed three times in the same buffer, eluted in 1 Â SDS-PAGE sample buffer, and subjected to SDS-PAGE/Western blotting.
35
S-labeled GATA-4 and c-Fos (or mutant) were detected by autoradiography. For in vivo coimmunoprecipitation, nuclear extracts were prepared from untransfected and Flag-GATA-4 transfected 293 cells. A monoclonal antiflag antibody covalently linked to agarose (Sigma) was used for immunoprecipitation as described in Morin et al. (2001) . The immunoprecipitate was subjected to SDS-PAGE and Western blotting. Polyclonal antibodies against GATA-4 (Santa Cruz) and c-Fos (Oncogene Science) were successively used to reveal protein presence.
Electrophoretic mobility shift assays (EMSA)
EMSAs were carried out as described previously for AP-1 (McBride and Nemer, 1998) and GATA binding (Charron et al., 1999) .
